Blockchain Registration Transaction Record

Nutriband to Present AVERSA Technology at MicroCap Rodeo Conference

Nutriband Inc. (NTRB) announces participation in MicroCap Rodeo Conference to present AVERSA abuse-deterrent technology for transdermal pharmaceuticals on Sept 25, 2025.

This announcement matters because it highlights Nutriband's innovative approach to addressing the critical public health crisis of opioid abuse through its AVERSA technology. With the ongoing opioid epidemic causing thousands of deaths annually from prescription drug misuse, technologies that prevent abuse of potent medications like fentanyl represent a vital advancement in patient safety. For investors, this conference presentation offers insight into a company developing solutions for a massive healthcare challenge while potentially creating significant shareholder value. The pharmaceutical industry is increasingly focused on abuse-deterrent formulations, and Nutriband's technology could position it as a key player in this growing market segment, making this development relevant to both healthcare stakeholders and investment communities.